Savannah McKenna

Ms. Savannah McKenna

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2023 in Viruses
Verified
Journal Article
Open access
PDF file
KJKwang Il Jung
Kwang Il Jung
SMSavannah McKenna
Savannah McKenna
VVVijayamahantesh Vijayamahantesh
Vijayamahantesh Vijayamahantesh
YHYing He
Ying He
Bumsuk HahmBumsuk Hahm
Bumsuk Hahm
Following virus infections, type I interferons are synthesized to induce the expression of antiviral molecules and interfere with virus replication. The importance of early antiviral type I IFN response against virus invasion has been emphasized during COVID-19 as well as in studies on the microbiome. Further, type I IFNs can directly act on various immune cells to enhance protective host immune responses to viral infections. However, accumulating data indicate that IFN responses can be harmful to the host by instigating inflammatory responses or inducing T cell suppression during virus infections. Also, inhibition of lymphocyte and dendritic cell development can be caused by type I IFN, which is independent of the traditional signal transducer and activator of transcription 1 signaling. Additionally, IFNs were shown to impair airway epithelial cell proliferation, which may affect late-stage lung tissue recovery from the infection. As such, type I IFN–virus interaction research is diverse, including host antiviral innate immune mechanisms in cells, viral strategies of IFN evasion, protective immunity, excessive inflammation, immune suppression, and regulation of tissue repair. In this report, these IFN activities are summarized with an emphasis placed on the functions of type I IFNs recently observed during acute or chronic virus infections.

1 January 2019 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
ELEdward O. List
Edward O. List
DBDarlene Berryman
Darlene Berryman
EJElizabeth A. Jensen
Elizabeth A. Jensen
PKPrateek Kulkarni
Prateek Kulkarni
SMSavannah McKenna
Savannah McKenna
JKJohn J. Kopchick
John J. Kopchick
In order to provide new insights into the various activities of GH in specific tissues, recent advances have allowed for the generation of tissue-specific GHR knockout mice. To date, 21 distinct tissue-specific mouse lines have been created and reported in 28 publications. Targeted tissues include liver, muscle, fat, brain, bone, heart, intestine, macrophage, pancreatic beta cells, hematopoietic stem cells, and multi-tissue "global". In this review, we provide a brief history and description of the 21 tissue-specific GHR knockout mouse lines. Arch Endocrinol Metab. 2019;63(6):557-67.

5 February 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
SMSavannah McKenna
Savannah McKenna
KJKwang Il Jung
Kwang Il Jung
BSBarbara Sumner
Barbara Sumner
JWJennifer J. Wolf
Jennifer J. Wolf
Lloyd W. SumnerLloyd W. Sumner
Lloyd W. Sumner
Bumsuk HahmBumsuk Hahm
Bumsuk Hahm
Influenza is a persistent public health concern worldwide. Elucidation of influenza A virus (IAV)-host interactions and identification of host factors that regulate IAV infection would be beneficial for combating and treating the disease. Ceramides, comprising a host sphingolipid family, have been shown to regulate virus infections. However, the effect of IAV on individual ceramides remains unknown. This study aimed to investigate the changes in ceramide species during infection of human lung epithelial A549 cells and human primary tracheal epithelial cells with IAV. We established a method utilizing UHPLC-MS analysis to measure individual ceramides (C14- through C26-ceramide). The results indicate that two main ceramide species, C16- and C24-ceramide, constitute approximately 80% of the ceramide population in human respiratory epithelial cells. Following IAV infection, these ceramides were found to undergo a shift in abundance, with a reduction in C16-ceramide and an increase in C24-ceramide, under various infection conditions. Primarily, IAV infection led to an increase in multiple long-chain ceramides. These findings could provide details for understanding how the ceramide system is disrupted during influenza virus infection and further support the ongoing efforts to understand influenza-host interactions.

10 March 2026 in Viruses
Verified
Journal Article
Open access
PDF file
SMSavannah McKenna
Savannah McKenna
KJKwang Il Jung
Kwang Il Jung
BSBarbara Sumner
Barbara Sumner
JWJennifer J. Wolf
Jennifer J. Wolf
Lloyd W. SumnerLloyd W. Sumner
Lloyd W. Sumner
Bumsuk HahmBumsuk Hahm
Bumsuk Hahm
Influenza is a persistent public health concern worldwide. The elucidation of influenza A virus (IAV)–host interactions and the identification of host factors that regulate IAV infection would be beneficial for combating and treating the disease. Ceramides, comprising a host sphingolipid family, have been shown to regulate virus infections. However, the effect of IAV on individual ceramides remains unknown. This study aimed to investigate the changes in ceramide species during the infection of human lung epithelial A549 cells and human primary tracheal epithelial cells with IAV. We established a method utilizing UHPLC-MS analysis to measure individual ceramides (C14- to C26-ceramide). The results indicate that two main ceramide species, C16- and C24-ceramide, constitute approximately 80% of the ceramide population in human respiratory epithelial cells. Following IAV infection, these ceramides were found to undergo a shift in abundance, with a reduction in C16-ceramide and an increase in C24-ceramide, under various infection conditions. Primarily, IAV infection led to an increase in multiple long-chain ceramides. These findings could provide details for understanding how the ceramide system is disrupted during influenza virus infection and to further support the ongoing efforts to understand influenza–host interactions.

5 July 2026 in bioRxiv
Verified
Preprint
Open access
KJKwang Il Jung
Kwang Il Jung
SMSavannah McKenna
Savannah McKenna
LJLei Jiang
Lei Jiang
HHHailey Huerter
Hailey Huerter
YHYing He
Ying He
Bumsuk HahmBumsuk Hahm
Bumsuk Hahm
Influenza viruses circulate in humans, causing a substantial burden on global health. Investigation of influenza-host interactions could identify host factors that regulate influenza pathogenicity. Sphingosine 1-phosphate (S1P) is a bioactive lipid mediator and regulates crucial cellular processes. S1P lyase (SPL), an enzyme that mediates S1P degradation, was shown to display anti-influenza activity in a cell culture system. Here, we constructed a mouse model to demonstrate the antiviral function of SPL in respiratory epithelial cells during influenza in vivo. Deletion of SPL from lung epithelial cells exacerbated influenza-induced weight loss and mortality. Influenza virus began to propagate more effectively in the absence of SPL at the innate immune stage. Increased virus titers were sustained during influenza and associated with enhanced accumulation of multiple immune cell types in the lungs. Single-cell RNA sequencing was conducted to further define the function of SPL in lung epithelial cells. SPL deletion increased the proportion of alveolar type 1 (AT1) cells compared to alveolar type 2 (AT2) cells with alteration of the related signaling pathways, suggesting a role of SPL in AT1/AT2 programming. Importantly, host innate defense pathways were changed in SPL-deficient lung epithelial cells upon infection, which corroborates the antiviral function of SPL. This study elucidates the host protective function of SPL in lung epithelial cells during influenza and provides gene signature profiles critical for SPL-mediated alleviation of influenza pathogenicity. The findings may contribute to development of host-directed therapeutics to better control influenza.